COVID-19 Funding Opportunities

Updated: September 22, 2020


 

Center for Disease Control and Prevention (CDC)
RFA-IP-21-005

Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States

Jan 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.

 

COVID-Related NIH Updates
NIH Late Application Policy
Information on the remdesivir NIH clinical trial
Information for NIH Applicants and Recipients of NIH Funding
Policy for charging Personal Protective Equipment to NIH grants

 

National Institutes of Health (NIH)
PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)  
PA-18-591

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

 
NOT-AI-20-065

Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2

Expires 9/1/2021
NOT-MD-20-025

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

Expires 5/8/2023
RFA-OD-20-023

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

Expires 10/1/2020
RFA-OD-20-019

Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)

Expires 10/1/2020
RFA-OD-20-016

Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

Expires 10/1/2020
RFA-TR-20-003

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)

Expires 1/24/2021
PAR-20-256

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)

Expires 7/8/2021
RFA-DK-20-021

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

Expires 12/17/2020
NOT-AI-20-059

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Expires 7/2/2021
PAR-20-243

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

Expires 3/3/2021
NOT-OD-20-129

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project

Expires 7/13/2021
PAR-20-237

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Expires 12/2/2020
NOT-TR-20-029

Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need

Expires 11/11/2020
PAR-20-234

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)

Expires 2/2/2021
NOT-MD-20-022

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

Expires 12/30/2020
NOT-MH-20-053

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

Expires 12/30/2020
NOT-DC-20-008

Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders

Expires 9/8/2022
RFA-RM-20-020

NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)

Expires 10/1/2020
NOT-AI-20-051

Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Expires 9/8/2021
NOT-DE-20-022

Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR

Expires 11/3/2020
NOT-DE-20-023

Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network

Expires 11/3/2020
NOT-NS-20-051

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System

Expires 4/15/2021
NOT-HL-20-782

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials

Expires 10/6/2020
NOT-TR-20-028

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs

Expires 11/11/2020
NOT-AA-20-011

Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA

Expires 4/16/2021
NOT-OD-20-097

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

Expires 4/1/2021
NOT-ES-20-020

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)

Expires 5/4/2021
NOT-MD-20-019

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities

Expires 5/1/2021
NOT-TR-20-017

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus

Expires 1/26/2022
NOT-MH-20-047

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus

Expires 4/16/2021
NOT-TR-20-016

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus

Expires 1/26/2022
NOT-AT-20-011

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)

Expires 10/7/2020
NOT-ES-20-015

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)

Expires 5/4/2021
NOT-AG-20-022

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

Expires 5/1/2021
NOT-TR-20-012

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)

Expires 10/17/2020
NOT-AI-20-031

Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

RESCINDED
NOT-GM-20-025

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2

2/6/2021
NOT-TR-20-011

Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need

7/10/2021
NOT-DA-20-047

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

3/31/2021
PA-20-135

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

9/8/2025

 

National Science Foundation (NSF)
NSF Supporting Research to Address Coronavirus Disease - blog post
NSF 20-052 Dear Colleague Letter to researchers inviting additional proposals
NSF 20-055 Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees

 

DOD Medical Technology Enterprise Consortium (MTEC)
Pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19)

 

Department of Energy
DOE Statement

 

Department of Defense

Request for Information for PPE in response to COVID-19

 

Other Coronavirus Funding Opportunities
COVID-19 Early Treatment Fund

The only organization in the world that exclusively funds outpatient clinical trials for COVID-19, CETF is narrowly focused on ensuring that outpatient trials for top drugs are successful, seeking the quickest, safest and lowest-cost way to repurpose drugs to dramatically reduce hospitalization rates.
The Rush Office of Philanthropy coordinates proposals to private foundations. Please contact Mary Marron at mary_marron@rush.edu.

Not accepting new grant applications at this time; visit link to sign up for notifications.
Fast Grants Fast Funding for COVID-19 Science
The Rush Office of Philanthropy coordinates proposals to private foundations. Please contact Mary Marron at mary_marron@rush.edu.
On hold since 4/14; visit link to sign up for notifications.